Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. (NYSE: BLND) files reports with the U.S. Securities and Exchange Commission as a Delaware corporation in the software publishers industry. On this BLND SEC filings page, Stock Titan aggregates the company’s regulatory disclosures, including current reports on Form 8-K and other periodic filings, and applies AI-powered summaries to help explain their contents in plain language.
Blend’s 8-K filings illustrate the types of material events the company reports to regulators and investors. Recent examples include the announcement of quarterly financial results, where Blend discusses software platform and professional services revenue, GAAP and non-GAAP gross margins, operating income or loss, and key operating metrics. Other 8-K filings cover leadership and executive transitions, such as changes in the Head of Finance and Administration role and related transition agreements, as well as appointments like the Head of Revenue.
Investors can also use this page to locate references to non-GAAP financial measures and the adjustments Blend applies, including stock-based compensation, workforce reduction costs, facilities-related charges, compensation realignment, litigation contingencies, transaction-related costs, software amortization and impairment, executive transition costs, and other items. These details are important for understanding how the company presents measures such as non-GAAP operating income and operating margin alongside GAAP results.
Stock Titan’s interface is designed to make it easier to work through Blend’s SEC disclosures. Users can quickly access quarterly and annual reports when available, review 8-K filings about results of operations, and see filings related to corporate governance or compensation matters. AI-generated highlights help surface the main points of each filing, including financial performance, key agreements, and leadership changes, so readers can navigate Blend’s regulatory history more efficiently.
Blend Labs (BLND) reported insider open‑market purchases by Haveli Brooks Aggregator, L.P. and affiliated reporting persons, who are listed as a Director and 10% Owner. On 11/10/2025 they bought 701,110 Class A shares at a weighted average price of $2.9839; on 11/11/2025 they bought 600,308 shares at $2.9986; and on 11/12/2025 they bought 953,634 shares at $3.0496.
After these transactions, the filing shows 5,931,971 shares beneficially owned indirectly, plus 130,000 shares held indirectly through a family trust. Prices reflect weighted averages with underlying trade details available upon request, as noted in the footnotes.
Blend Labs (BLND) reported Q3 results showing steady revenue and a swing to GAAP profitability. Total revenue was $32.860 million versus $33.104 million a year ago, as stronger Consumer Banking Suite offset softer Mortgage Suite. Gross profit was essentially flat, while operating loss narrowed to $4.911 million from $11.283 million on lower R&D and sales and marketing spend.
GAAP net income was $12.532 million, aided by $16.6 million of gains from a non‑marketable equity investment; net income attributable to common stockholders was $7.974 million, or $0.03 basic ($0.02 diluted) per share. Cash and cash equivalents were $55.021 million and marketable securities were $22.234 million. Deferred revenue rose to $25.325 million. Remaining performance obligations totaled $189.0 million, with approximately half expected to be recognized over the next 12 months. The Title business is classified as discontinued operations. As of October 31, 2025, Class A shares outstanding were 256,119,535 and Class B shares were 3,627,385.
Blend Labs (BLND) furnished a current report announcing it issued a press release with financial results for the fiscal quarter ended September 30, 2025 and posted supplemental investor materials on its investor relations website.
The information under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure), along with Exhibit 99.1 (press release), was furnished and is not deemed filed for purposes of Section 18 of the Exchange Act. Blend also notes it distributes material information through SEC filings, press releases, public calls/webcasts, its investor site, blog, and X account to support broad disclosure.
Blend Labs (BLND) reported an equity grant to an officer on a Form 4. The Head of Finance and Administration received 2,200,000 restricted stock units (RSUs) on October 27, 2025, each representing one share of Class A common stock.
Per the award terms, 25% vests on August 20, 2026, with the remainder vesting in equal quarterly installments over the following three years, contingent on continued service. Following the grant, 2,200,000 derivative securities were reported as directly owned.
Blend Labs (BLND): insider equity change reported. A director and officer (Head of Blend) reported a transaction on 10/29/2025. The filing shows 371,000 shares of Class A Common Stock were acquired at a price of $0 under transaction code J, with total Class A beneficial ownership at 6,428,300 shares directly after the transaction.
The related note states that upon conversion of shares of Class B Common Stock, an equal number of Class A shares were pledged as collateral to secure certain personal indebtedness. Following the event, the reporting person also held 2,756,385 shares of Class B Common Stock, which are convertible into Class A on a one-for-one basis and have no expiration date.
Blend Labs (BLND) disclosed an insider transaction by its Head of Legal and People. On 10/20/2025, the reporting person sold 4,000 Class A shares at $3.50 per share under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the sale, the insider beneficially owned 380,631 shares, held directly.
Blend Labs (BLND) reported an insider transaction by its Head of Revenue. On 10/15/2025, the reporting person sold 25,000 shares of Class A common stock at a $3.3403 weighted average price, with individual trades ranging from $3.33 to $3.385. The sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the transaction, the insider beneficially owns 687,909 shares, held directly.
Blend Labs (BLND) received a Form 144 notice indicating an intended sale of 25,000 shares of common stock through Charles Schwab & Co., Inc. with an aggregate market value of $83,509, targeting an approximate sale date of October 15, 2025 on the NYSE. The form lists 255,696,747 shares outstanding.
The seller acquired these 25,000 shares on February 17, 2020 via “Exercise and Hold,” paid in cash. Recent activity disclosed three prior sales of 25,000 shares each on July 15, 2025 ($90,829), August 15, 2025 ($71,873), and September 15, 2025 ($109,069), by Brian Kneafsey.
Reporting person: Winnie Ling, Head of Legal and People and officer of Blend Labs, Inc. (BLND), reported a sale of common stock executed under a Rule 10b5-1 trading plan adopted on 03/14/2025.
The Form 4 shows a disposition of 4,000 shares of Class A common stock on 10/02/2025 for a weighted average sale price of $3.5845 per share (sales ranged from $3.545 to $3.65). After the reported sale, the reporting person beneficially owned 384,631 shares, held directly.
Blend Labs, Inc. outlined a transition for its previous Head of Finance and Administration, Amir Jafari. His employment ends on October 3, 2025, after which he will serve as a strategic advisor to the Head of Blend and the company through January 1, 2026.
During this advisor period, Jafari will receive payments equivalent to his regular base salary and company-paid COBRA benefits, and his outstanding equity awards will continue to vest under their existing terms. After the advisor period, and subject to his compliance with the transition terms and signing a supplemental release, he will receive an additional $200,000.
If, at any time during the advisor period, the closing price of Blend’s Class A common stock reaches at least $7.00 per share, then 325,000 performance-based restricted stock units from his March 13, 2025 grant will vest upon the effectiveness of the supplemental release.